Skip to main content
. 2020 Nov 11;11:592553. doi: 10.3389/fimmu.2020.592553

Figure 9.

Figure 9

Target antigen expression on PBMC. Data is displayed as the average median fluorescent intensity (MFI) ± SD (N = 5). PBMC were stained using the following drugs: siplizumab (Target antigen CD2), Alemtuzumab (CD52) and rATG (Thymocyte antigens). After removal of unbound antibody, samples were stained with a secondary anti-human IgG antibody and MFI for the secondary antibody was recorded, representing the expression of the respective transplant antigens. Tcm, central memory T cells; Tem, effector memory T cells; Temra, effector-memory CD45RA+ T cells; rTreg, resting regulatory T cells; nsTreg, non-suppressive Treg; aTreg, activated Treg; CD56Bright, CD56bright NK cells; CD56Dim, CD56 dim NK cells; CD56neg CD16+, CD56 CD16+ NK cells.